Antisense IL-10 abrogates the inhibitory effects of IL-10 production by transfected tumor cells

被引:0
|
作者
Parker, G [1 ]
Fernandes, H [1 ]
Chong, SY [1 ]
Czarneski, J [1 ]
Ra, H [1 ]
Lin, YC [1 ]
Raveche, E [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol, Newark, NJ 07103 USA
关键词
tumor immunity; cytokines; IL-10; gene therapy; in vivo animal models;
D O I
10.1080/mccm.6.3.113.119
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Interleukin-10 (IL-10) is a pleiotropic cytokine that has a variety of downregulatory effects on immunologic and inflammatory processes. Ectopic tumor expression of IL-10 inhibited tumor growth, and local administration of antisense IL-10 significantly reversed the effects of IL-10 transfection in P815 mastocytoma. Tissue inhibitors of metalloproteinase (TIMPs) have been associated with decreased tumorigenesis and reduced metastasis, and TIMPs were increased in the region surrounding P815/IL-10 tumors and reduced in antisense IL-10-treated mice. in addition, the antisense IL-10 group had the largest tumor volume and poorest survival when compared with the P815/IL-10 control or sense groups. In summary, our data suggest that, in a mouse model, antisense IL-10 has substantive effects in reducing IL-10 translation and inhibiting IL-10-mediated TIMP upregulation, and, by doing so, allows IL-10-transfected mastocytoma to grow unchecked. Thus, ectopic tumor expression of IL-10 inhibits tumor growth, and antisense IL-10 administration in vivo reverses this protective effect.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [21] ELEVATED IL-10 LEVEL IN A PATIENT WITH IL-10 RECEPTOR DEFICIENCY
    LaBarba, S.
    Bonagura, V.
    Jongco, A.
    Sahn, B.
    Lim, C. E.
    Glocker, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A87 - A87
  • [22] IL-10, an inflammatory/inhibitory cytokine, but not always
    Conti, P
    Kempuraj, D
    Kandere, K
    Di Gioacchino, M
    Barbacane, RC
    Castellani, ML
    Felaco, M
    Boucher, W
    Letourneau, R
    Theoharides, TC
    IMMUNOLOGY LETTERS, 2003, 86 (02) : 123 - 129
  • [23] Paradoxical priming effects of IL-10 on cytokine production
    Adib-Conquy, M
    Petit, AF
    Marie, C
    Fitting, C
    Cavaillon, JM
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (05) : 689 - 698
  • [24] AN INTERLEUKIN-10 (IL-10) INHIBITORY FACTOR (IL-10IF) FROM PLATELETS
    LASLEY, MV
    LU, LJ
    FISHER, RH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 170 - 170
  • [25] Interleukin-10 (IL-10) augments allograft arterial disease - Paradoxical effects of IL-10 in vivo
    Furukawa, Y
    Becker, G
    Stinn, JL
    Shimizu, K
    Libby, P
    Mitchell, RN
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06): : 1929 - 1939
  • [26] PEGylated IL-10
    Coburn, Cassandra
    LANCET ONCOLOGY, 2016, 17 (06): : 708 - 708
  • [27] IL-10 in glioma
    Widodo, Samuel S.
    Dinevska, Marija
    Furst, Liam M.
    Stylli, Stanley S.
    Mantamadiotis, Theo
    BRITISH JOURNAL OF CANCER, 2021, 125 (11) : 1466 - 1476
  • [28] REGULATION OF CLL BY INTERLEUKIN-10 - ROLE OF ANTISENSE IL-10
    FERNANDES, H
    BARCHUK, W
    FERNANDES, G
    RAMACHANDRA, S
    CHOU, CC
    RAVECHE, E
    ONCOLOGY REPORTS, 1995, 2 (06) : 985 - 989
  • [29] IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia
    Yao Chenjiao
    Fan Zili
    Chen Haibin
    Liu Ying
    Xiao Sheng
    Huang Lihua
    Du Wei
    PHARMAZIE, 2013, 68 (03): : 201 - 206
  • [30] IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice
    Nagelkerken, L
    Blauw, B
    Tielemans, M
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (09) : 1243 - 1251